URochester Health Research

06/08/2026

Should cancer patients exercise?

Researchers at Wilmot Cancer Institute are studying how exercise impacts common side effects of cancer and treatment. Their work is uncovering new ways to help patients improve their quality of life during and after treatment.

Research from URochester Medicine Wilmot Cancer Institute shows exercise can help reduce chemo brain, fatigue, anxiety, and other side effects of cancer treatment. Here’s what studies reveal about staying active during and after cancer care.

06/05/2026

What to know about air pollution and brain health

Air pollution is back in the spotlight because of more frequent wildfires and efforts to roll back air quality regulations in the US and around the world. URochester Medicine experts share why this matters not only for your lungs but also for your brain.

Discover how air pollution affects brain health in children and adults. URochester Medicine researchers reveal links to learning difficulties, dementia, and Parkinson's—plus steps you can take to protect yourself and your family.

06/02/2026

Want to feel more loved? You’re probably going about it the wrong way

Harry Reis, a Dean’s Professor in Arts & Sciences and a professor of psychology, has coauthored How to Feel Loved: The Five Mindsets That Get You More of What Matters Most, a treatise on how to bring more compassion, acceptance, and vulnerability to our relationships.

Los Angeles Times, June 1
https://www.sacbee.com/entertainment/living/article315961242.html

06/02/2026

WCI Awarded $7.7M Grant for Clinical Trials

Paul Barr, professor of Hematology & Oncology, leads the new grant from the National Cancer Institute, which recognizes Wilmot’s leadership in enrolling patients to large, practice-changing cooperative group clinical trials. It enables the cancer center to support groundbreaking studies for the next six years.

Each clinical trial is a team effort to bring the best care to patients.

06/01/2026

AI reveals how the brain clears harmful waste

A new approach to studying the glymphatic system, outlined in a study led by Douglas Kelley, a professor of mechanical engineering and a senior scientist at the Laboratory for Laser Energetics, combines MRI scans and AI tools to measure fluid flow linked to diseases such as Alzheimer’s.

The new approach combines MRI scans and AI tools to measure fluid flow linked to diseases such as Alzheimer’s.

05/21/2026

What matters most for a baby’s gut
Dr. Hitesh Deshmukh offers information on what matters most in shaping a baby’s long-term gut health.

A baby’s gut microbiome starts developing from the moment they’re born, and those early days can have a lasting impact on immune health and development.

05/06/2026

Infectious disease specialist David Dobrzynski, MD, spoke to Rochester First (April 22) about Lyme disease vaccine trials showing promise but with some lingering questions. “Is this a vaccine you have to get every year, like the flu vaccine, or can you get it every other year or every five years? I think that is the biggest remaining question we all have,” Dobrzynski said.

ROCHESTER, N.Y. (WROC) — We’re learning more today about where we stand on a Lyme disease vaccine. We reported earlier this week that two vaccines are going through clinical trials. An infect…

04/28/2026

Why does my shoulder hurt?

Ilya Voloshin, a professor of orthopaedics, offers advice on protecting your shoulders from injury and when to seek treatment.

The shoulder is the most complex and mobile joint in the body, making it especially vulnerable to injury no matter your age. Orthopaedics experts offer advice on protecting your shoulders from injury and when to seek treatment.

04/28/2026

NIH Backs Ruchira Singh’s AMD Treatment Research

The associate professor of Ophthalmology will advance research of a next-generation treatment approach for age-related macular degeneration, a leading cause of vision loss in older adults. The project focuses on the protein sPLA2-IIA, which Singh's Flaum Eye Institute team has identified as a potential early driver of the disease.

The project will advance research on a new treatment approach for age-related macular degeneration (AMD), focusing on a protein identified as a potential early driver of disease.